SUZ12 anticorps (C-Term)
-
- Antigène Voir toutes SUZ12 Anticorps
- SUZ12 (SUZ12 Polycomb Repressive Complex 2 Subunit (SUZ12))
-
Épitope
- C-Term
-
Reactivité
- Humain, Souris, Boeuf (Vache)
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SUZ12 est non-conjugé
-
Application
- Western Blotting (WB)
- Réactivité croisée
- Souris, Boeuf (Vache)
- Purification
- Purified
- Immunogène
- SUZ12 antibody was raised in rabbit using the C terminal of SUZ12 as the immunogen
- Top Product
- Discover our top product SUZ12 Anticorps primaire
-
-
- Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
SUZ12 Blocking Peptide, catalog no. 33R-2719, is also available for use as a blocking control in assays to test for specificity of this SUZ12 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Antigène
- SUZ12 (SUZ12 Polycomb Repressive Complex 2 Subunit (SUZ12))
- Autre désignation
- SUZ12 (SUZ12 Produits)
- Sujet
- A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t (7,17)(p15,q21) with JAZF1 generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. Synonyms: Polyclonal SUZ12 antibody, Anti-SUZ12 antibody, suppressor of zeste 12 homolog, Drosophila antibody, CHET9 antibody, JJAZ1 antibody, KIAA0160 antibody.
-